Table 1.
Patient characteristics.
| ID | Main diagnosis | Comorbid psychiatric disorders | Medication change during study | Medication at time point 1 | Medication at time point 2 | Medication at time point 3 | Current psychotherapy | Previous treatment with | |
|---|---|---|---|---|---|---|---|---|---|
| ECT | Ketamine | ||||||||
| 1 | F33.2 | yes | Lamotrigine 100 mg | n.a. | n.a. | x | x | ||
| 2 | F33.1 | F41.0, F40.2, F90.0 | no | Quetiapine 25 mg | Quetiapine 25 mg | Quetiapine 25 mg | x | x | |
| 3 | F33.2 | F60.6, F60.7 | yes | Paroxetine 30 mg | Paroxetine 25 mg | Escitalopram 15 mg, Pregabalin 150 mg | x | ||
| 4 | F33.1 | no | n.a. | n.a. | n.a. | x | |||
| 5 | F33.1 | no | Clomipramine 75 mg, Buspirone 10 mg | Clomipramine 75 mg, Buspirone 10 mg | Clomipramine 75 mg, Buspirone 10 mg | x | |||
| 6 | F33.1 | no | Sertraline 125 mg, Duloxetine 60 mg | Sertraline 125 mg, Duloxetine 60 mg | Sertraline 125 mg, Duloxetine 60 mg | ||||
| 7 | F33.1 | F90.0, F60.3 | yes | Escitalopram 20, Methylphenidate 20 mg, Zolpidem 5 mg | Escitalopram 20 mg, Methylphenidate 20 mg, Aripiprazol 3 mg, Valdoxan 25 mg | Escitalopram 20 mg, Methylphenidate 10 mg, Aripiprazole 4 mg, Zolpidem 10 mg | |||
| 8 | F33.1 | no | Zoldem 10 mg, Chlorprotixene 100 mg, Tranylcypromine 40 mg | Zoldem 10 mg, Chlorprotixene 100 mg, Tranylcypromine 40 mg | Zoldem 10 mg, Chlorprotixene 100 mg, Tranylcypromine 40 mg | x | x | ||
| 9 | F33.3 | F43.1 | yes | Levomepromazine 100 mg, Lithium 675 mg, Tranylcypromine 45 mg, Bupropion 450 mg | Tranylcypromine 30 mg, Bupropion 150 mg, Prothipendyl 160 mg, Aripiprazole 5 mg, Lithium 450 mg | Tranylcypromine 30 mg, Bupropion 150 mg, Prothipendyl 160 mg, Aripiprazole 5 mg, Lithium 450 mg | x | x | x |
| 10 | F33.1 | yes | n.a. | n.a. | Venlafaxine 300 mg, Mirtazapine 45 mg, Esketamine nasalspray (once/week) | ||||
| 11 | F33.1 | yes | n.a. | Trazodone 100 mg | Bupropion 300 mg, Trazodone 150 mg | ||||
| 12 | F33.1 | yes | Venlafaxine 150 mg, Mirtazapine 30 mg | Venlafaxine 150 mg, Trazodone 50 mg | Venlafaxine 150 mg, Trazodone 50 mg | ||||
| 13 | F33.1 | F90.0 | yes | n.a. | Methylphenidate 30 mg, Aripiprazole 3 mg, Quetiapine 25 mg | Methylphenidate 40 mg, Quetiapine 25 mg | |||
| 14 | F33.1 | no | Milnacipran 50 mg, Pegabalin 300 mg, Trazodone 100 | Milnacipran 100 mg, Pregabalin 350 mg, Trazodone 150 mg | Milnacipran 100 mg, Pregabalin 350 mg, Trazodone 150 mg | x | |||
| 15 | F33.1 | F61 | yes | n.a. | n.a. | Venlafaxine 300 mg, Lamotrigine 100 mg | x | ||
| 16 | F33.2 | no | Bupropion 600 mg, Flupentixol/Melitracen, Milnacipran 50 mg | Bupropion 600 mg, Flupentixol/Melitracen, Milnacipran 50 mg | Bupropion 600 mg, Flupentixol/Melitracen, Milnacipran 50 mg | ||||
| 17 | F33.1 | F90.0, F60.3 | yes | n.a. | n.a. | Venlafaxine 75 mg, Qeutiapine 25 mg, Methylphenidate 30 mg | |||
| 18 | F33.1 | no | Sertraline 50 mg, Bupropion 150 mg, Lorazepam 1 mg | Sertraline 50 mg, Bupropion 150 mg, Lorazepam 1 mg | Sertraline 50 mg, Bupropion 150 mg, Lorazepam 1 mg | x | x | ||
ECT electroconvulsive therapy